美林报告 ML - September 21, 2009 - Competitive trends in key Therapy area

相似文件 换一批

是 否 +2 论坛币

k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群

赵安豆老师微信：zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

立即领取

感谢您参与论坛问题回答

经管之家送您两个论坛币！

+2 论坛币

Equity | Pan-Europe | Pharmaceuticals
21 September 2009
Competitive trends in key therapy areas – August 09 data
38 pages

Competitive analysis of major therapeutic classes
We provide a monthly competitive market share and growth analysis of the major
therapeutic drug classes of interest to investors for the US market. We use
monthly prescription data for retail and mail order pharmacies sourced from
IMS Health.

New product approvals and patent expiries
We highlight key upcoming product approvals, patent expires and other events
that could impact class dynamics.

Market shares, growth rates and sales forecasts
We highlight category market shares, total prescription growth rates and, where
applicable, Banc of America Securities - Merrill Lynch sales forecasts

US drug market +3% in August (actual), +2.1% (adjusted)
Table 1: Total US market Rx Growth
4Q08 1Q09 2Q09 QTD Aug YoY 12m MAT
Total Market TRx 0.7% -0.2% 3.4% 2.9% 3.0% 1.9%
Total Market NRx 1.4% 0.1% 5.1% 1.6% 3.7% 2.4%
Source: IMS Health
On an actual basis, the US prescription drug market was up 3.0% in August,
versus up 2.8% in July and 1.9% 12 month MAT growth. On an adjusted basis
(which takes into account the number of days in a given month for a year-on-year
comparison), August volumes were up 2.1% versus July volumes up 3.9%.

扫码加我 拉你入群

请注明：姓名-公司-职位

以便审核进群资格，未注明则拒绝

分享0 收藏0 回帖

关键词：competitive September Therapy Trends Petit 美林 Key competitive area Therapy

贵啊~~~~~~~~~~··